Results 101 to 110 of about 2,581 (157)

Is There a Role for Lumacaftor/Ivacaftor in Young Children with Cystic Fibrosis? [PDF]

Ann Am Thorac Soc
Martin I, Grasemann H.
europepmc   +1 more source

CFTR acts as a potential therapeutic target for attention deficit-hyperactivity disorder. [PDF]

Sci Rep
Li Q, Wang T, Li J, Lin X.
europepmc   +1 more source

Reply to Martin and Grasemann: Is There a Role for Lumacaftor/Ivacaftor in Young Children with Cystic Fibrosis? [PDF]

Ann Am Thorac Soc
Stahl M, Röhmel J, Wielpütz MO, Mall MA.   +3 more
europepmc   +1 more source

Cutaneous Adverse Effects of Elexacaftor-Tezacaftor-Ivacaftor: A Single Center Cohort Study on Acne Severity in Adults With Cystic Fibrosis. [PDF]

J Cosmet Dermatol
Smith AD, Lyons CE, Somerville L, Flowers RH, Kaplan E, Albon D.   +5 more
europepmc   +1 more source

Cystic Fibrosis and CFTR Modulators: The Impact on Bone Density, Muscle Mass and Strength in Children and Young Adolescents. [PDF]

Children (Basel)
Iordanidou K, Karakousis ND, Hatziagorou E, Chrysochoou EA, Galogavrou M, Sopiadou A, Papagianni M.   +6 more
europepmc   +1 more source

Hemoglobin Levels in Children Treated for Cystic Fibrosis with CFTR Modulators: A Single Center Retrospective Study. [PDF]

J Clin Med
Tosco A, Cerchione R, Gelzo M, Cimbalo C, Castaldo A, Terracciano R, Raia V, Sepe A.   +7 more
europepmc   +1 more source

Bioinformatics identification of key genes correlating NOD1 and Endoplasmic Reticulum stress in Hepatitis B virus-induced acute liver failure. [PDF]

Sci Rep
Deng F, Jiang W, Wang N, Wu Y, Xu J, Hou R, Jia F.   +6 more
europepmc   +1 more source

Cystic Fibrosis Treatment Landscape: Progress, Challenges, and Future Directions. [PDF]

Turk Arch Pediatr
Yıldız CA, Gökdemir Y, Erdem Eralp E, Ergenekon P, Karakoç F, Karadağ B.   +5 more
europepmc   +1 more source

Induced Pluripotent Stem Cells (iPSC) and Their Use in Disease Modeling. [PDF]

Cureus
Dorota A, Maryniak N, Mariankowska A, Milczarek C, Dorota M, Zywiec W, Kozlowski K, Koval I, Czyzewski B, Czyzewska J.   +9 more
europepmc   +1 more source

Comparison of the Effect of CFTR Modulators <i>elexacaftor</i>/<i>tezacaftor</i>/<i>ivacaftor</i> and <i>lumacaftor</i>/<i>ivacaftor</i> via Serum Human Epididymis Protein 4 Concentration in <i>p.Phe508del-CFTR</i> Homozygous Cystic Fibrosis Patients. [PDF]

J Clin Med
Pócsi M, Fila L, Péterfia C, Halász A, Szanto TG, Mészáros B, Major J, Laki I, Szabó H, Panyi G, Balogh I, Amaral MD, Macek M, Nagy B.   +13 more
europepmc   +1 more source